NEWS / BLOG
Gentronix News and Blog section gives you our latest company updates, comments on the field of toxicology and insights into our business, values and commitment to our clients.
LATEST NEWS
Gentronix proud to sponsor the annual IGG meeting 2019
Gentronix is proud to sponsor the annual Industrial Genotoxicity Group (IGG) meeting this week in Manchester. It is Gentronix’s 20th birthday this summer, and sponsoring IGG in the ci [...]
Gentronix are Presenting at the EEMGS 2019 Meeting
Gentronix Managing Director Matt Tate will attend the EEMGS meeting in Rennes from the 19-23th of May and showcase our science. Matt will be presenting a poster comparing 24-well and [...]
GTTC and GTA are coming
Gentronix experts will attend the HESI genetic toxicology technical committee (GTTC) and genetic toxicology Association (GTA) meetings in the USA this week. Our founder, Richard Walms [...]
BLOG
Gentronix’s In Vitro Micronucleus Assay Offerings
Micronucleus assay used in genetic toxicology Micronucleus assays have been extensively used in genotoxicity assessment for decades. Tests were for many years conducted in vivo in the [...]
Setting Up Skin Sensitisation at Gentronix
The emergence of skin sensitisation assessment as an in vitro science Until the last few years, testing chemicals for skin sensitisation potential was primarily conducted using animal [...]
An Introduction to Non-animal Skin Sensitisation Testing
In Vitro Skin Sensitisation Assays As described in a previous blog, the prediction of skin sensitisation is an important part of risk assessment for many types of chemicals. Historica [...]
OUR VALUES
OUR VALUES
Our business origins are in the delivery of innovative screening products for toxicological hazard; challenging the established approach with scientific rigour. Building on our experiences of developing market leading predictive toxicology assays, we have extended our expertise to the regulatory tests for genetic toxicology and recently skin sensitisation.
We make a commitment to our clients to perform toxicology studies of the highest scientific quality; not merely to produce data, but to deliver the most appropriate data endpoints, using the right assay tools, guided by scientific engagement and experience. Furthermore, we are committed to helping our clients understand and interpret their results, supporting navigation of regulatory landscapes and management of adverse toxicology findings.
This is guided by our core values, which we apply to all the studies we perform:
Our business origins are in the delivery of innovative screening products for toxicological hazard; challenging the established approach with scientific rigour. Building on our experiences of developing market leading predictive toxicology assays, we have extended our expertise to the regulatory tests for genetic toxicology and recently skin sensitisation.
We make a commitment to our clients to perform toxicology studies of the highest scientific quality; not merely to produce data, but to deliver the most appropriate data endpoints, using the right assay tools, guided by scientific engagement and experience. Furthermore, we are committed to helping our clients understand and interpret their results, supporting navigation of regulatory landscapes and management of adverse toxicology findings.
This is guided by our core values, which we apply to all the studies we perform:
LATEST VACANCIES
At Gentronix, we have a passion for the science of toxicology. Building on our experience gained from the pharmaceutical, agrochemical and CRO industries, we are committed to engaging with our clients to deliver the highest quality to science to support their projects. If believe you have the toxicology knowledge and the interest to support us in delivering this commitment, we’re interested to learn more.